In vitro susceptibility of Pseudomonas aeruginosa isolated from a burn center to silver sulfadiazine and silver nitrate in Shiraz, South of Iran

Iranian Journal of Medical Sciences

Volumn 30, Issue 2, 2005, Pages 63-67

  Japoni, Aziz ^a   Hayati, M ^a   Alborzi, A ^a   Farshad, Sh ^a   Abbasian, S A ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Pseudomonas aeruginosa; Silver nitrate; Silver sulfadiazine

Indexed keywords

SILVER NITRATE; SULFADIAZINE SILVER;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BURN INFECTION; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; IRAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OINTMENT; POWDER; PSEUDOMONAS AERUGINOSA; STATISTICAL ANALYSIS;

EID: 26044449401     PISSN: 02530716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vasil ML, Ochsner UA. The response of Pseudomonas aeruginosa to iron: genetics, biochemistry and virulence. Mol Microbiol 1999; 34: 399-413.
2. Tredget EE, Shankowsky HA, Joffe AM, et al. Epidemiology of infections with Pseudomonas aeruginosa in burn patients: the role of hydrotherapy. Clin Infect Dis 1992; 15: 941-9.
3. Silver S. Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 2003; 27: 341-53.
4. Fox CL. Silver sulfadiazine - a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg 1968; 96: 184-8.
5. Lowbury EJ, Babb JR, Bridges K, Jackson DM. Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant Gram-negative bacilli. Br Med J 1976; 1: 493-6.
6. Hendry AT, Stewart IO. Silver-resistant Enterobacteriaceae from hospital patients. Can J Microbiol 1979; 25: 915-21.
7. Starodub ME, Trevors JT. Silver resistance in Escherichia coli R1. J Med Microbiol 1989; 29: 101-10.
8. Pirnay JP, De Vos D, Cochez C, et al. Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multi drug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbiol 2003; 41: 1192-202.
9. Vasishta R, Saxena M, Chhibber S. Contribution of silver ion resistance to the pathogenicity of Pseudomonas aeruginosa with special reference to burn wound sepsis. Folia Microbiol 1991; 36: 498-501.
10. Daikos GL, Lolans VT, Jackson GG. Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones. Antimicrob Agents Chemother 1988; 32: 785-7.
11. Bridges K, Kidson A, Lowbury EJ, Wilkins MD. Gentamicin and silver-resistant pseudomonas in a burns unit. Br Med J 1979; 1: 446-9.
12. Hendry AT, Stewart IO. Silver-resistant Enterobacteriaceae from hospital patients. Can J Microbiol 1979; 25: 915-21.
13. Rosenkranz HS, Coward JE, Wlodkowski TJ, Carr HS. Properties of silver sulfadiazine-resistant Enterobacter cloacae. Antimicrob Agents Chemother 1974; 5: 199-201.
14. Gupta A, Maynes M, Silver S. Effects of halides on plasmid-mediated silver resistance in Escherichia coli. Appl Environ Microbiol 1998; 64: 5042-5.
15. Nakayama K, Kanaya S, Ohnishi M, et al. The complete nucleotide sequence of phi CTX, a cytotoxin-converting phage of Pseudomonas aeruginosa: implications for phage evolution and horizontal gene transfer via bacteriophages. Mol Microbiol 1999; 31: 399-419.
16. Krishnapillai V, Royle P, Lehrer J. Insertions of the transposon Tn1 into the Pseudomonas aeruginosa chromosome. Genetics 1981; 97: 495-511.
17. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997; 10: 781-91.
18. Nikaido H. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother 1989; 33: 1831-6.
19. Nikaido H. Multidrug efflux pumps of gram-negative bacteria. J Bacteriol 1996; 178: 5853-9.
20. Poole K, Krebes K, McNally C, Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 1993; 175: 7363-72.
21. Li XZ, Poole K, Nikaido H. Contributions of MexAB-OprM and an EmrE homolog to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes. J Antimicrob Chemother 2003; 47: 27-33.
22. Muller MJ, Hollyoak MA, Moaveni Z, et al. Retardation of wound healing by silver sulfadiazine is reversed by Aloe vera and nystatin. Burns 2003; 29: 834-6.
23. Fraser JF, Bodman J, Sturgess R, et al. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. Burns 2004; 30: 35-41.
24. Holder IA, Durkee P, Supp AP, Boyce ST. Assessment of a silver-coated barrier dressing for potential use with skin grafts on excised burns. Burns 2003; 29: 445-8.
25. Ohura T, Sanada H, Mino Y. Clinical activity based cost effectiveness of traditional versus modern wound management in patients with pressure ulcers. Wounds 2004; 16: 157-63.